Skip to content

Turn regulatory intelligence into action – from surveillance to strategic impact

November 18, 2025

03:00 PM BST / 10:00 AM EST

Virtual

Transform regulatory updates into business value. Most regulatory teams excel at surveillance but struggle with activation. Join Chris Whalley from Pfizer and industry experts as they reveal how leading organizations bridge the gap between regulatory intelligence and measurable business outcomes.

Team of working professionals in an office looking at a tablet

Overview

Most regulatory teams excel at tracking updates but struggle to turn them into measurable outcomes. Our Regulatory Intelligence Forum will show you how to move from monitoring information to activating it, with structure, speed, and accountability. Join Chris Whalley, Senior Director and Head of Global Regulatory Intelligence and Analysis at Pfizer, and industry experts as they share practical frameworks that help organizations connect intelligence to business impact.

Man and woman smiling at a laptop

What you’ll learn:

  • How to turn regulatory updates into structured, auditable workflows.
  • How to replace spreadsheets and email threads with systematic impact assessments.
  • Proven ways to coordinate response and accountability across functions.
  • Real examples of audit-ready documentation that supports compliance and leadership trust.
InfoDesk logo

Your host

Chris Whalley

Senior Director and Head of Global Regulatory Intelligence & Analysis, Pfizer

 

Smiling working professional sitting at a desk and working

What to expect

Watch highlights from our previous session, ‘From Insight to Impact: The Role of Regulatory Intelligence in Strategy’, and discover how leading organizations are activating intelligence when action matters most. See how experts from Pfizer, Haleon, and AstraZeneca are redefining the role of regulatory intelligence.